Literature DB >> 1680658

Metabolism of nicotine by rat liver cytochromes P-450. Assessment utilizing monoclonal antibodies to nicotine and cotinine.

D K Hammond1, R J Bjercke, J J Langone, H W Strobel.   

Abstract

Because of the prevalence of cigarette smoking in the general population and because studies suggest that a large percentage of nicotine is metabolized to cotinine in humans, it is important to study the enzymes responsible for nicotine metabolism. The cytochromes P-450 have long been implicated in the first step in the conversion of nicotine to nicotine delta 1'(5')-iminium ion. We demonstrate here that rat liver P-450IIB1 is able to convert nicotine to cotinine in the presence of cytosol with a Km of 5-7 microM. A constitutive form of P-450 is also implicated in nicotine metabolism, while purified P-450IA1 and P-450IIC6 show no detectable activity. The lack of P-450IA1 activity substantiates work by others who also failed to observe an increase in the efficiency of nicotine metabolism to cotinine by microsomes from rats that had been pretreated with benzanthracene. This result is in contrast to work with purified rabbit liver enzymes, in which P-450IA1 exhibited low but measurable activity. Our results support the notion that nicotine metabolism to cotinine by P-450 enzymes is highly species dependent. Thus, it is unwise in some cases to extrapolate results obtained by animal model study to the possible role of specific forms of the P-450 enzymes in nicotine metabolism in humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680658

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  11 in total

1.  Prolonging the Reduction of Nicotine Self-Administration in Rats by Coadministering Chronic Nicotine With Amitifadine, a Triple Monoamine Reuptake Inhibitor With CYP2B6 Inhibitory Actions.

Authors:  Edward D Levin; Corinne Wells; Susan Slade; Michelle Lee; Anthony A McKinney; Jed E Rose; Amir H Rezvani
Journal:  Nicotine Tob Res       Date:  2020-02-06       Impact factor: 4.244

2.  Nicotine pharmacokinetics in rats is altered as a function of age, impacting the interpretation of animal model data.

Authors:  Evelyn L Craig; Bin Zhao; Jason Z Cui; Maria Novalen; Sharon Miksys; Rachel F Tyndale
Journal:  Drug Metab Dispos       Date:  2014-06-30       Impact factor: 3.922

Review 3.  PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6.

Authors:  Ellen M McDonagh; Catherine Wassenaar; Sean P David; Rachel F Tyndale; Russ B Altman; Michelle Whirl-Carrillo; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-09       Impact factor: 2.089

4.  Effect of Brain CYP2B Inhibition on Brain Nicotine Levels and Nicotine Self-Administration.

Authors:  Kristine L P Garcia; Kathy Coen; Sharon Miksys; Anh Dzung Lê; Rachel F Tyndale
Journal:  Neuropsychopharmacology       Date:  2015-02-05       Impact factor: 7.853

Review 5.  Pathophysiology of alcoholic pancreatitis: an overview.

Authors:  Parimal Chowdhury; Priya Gupta
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

6.  Effects of pregnancy on nicotine self-administration and nicotine pharmacokinetics in rats.

Authors:  Mark G Lesage; Daniel E Keyler; Danielle Burroughs; Paul R Pentel
Journal:  Psychopharmacology (Berl)       Date:  2007-07-07       Impact factor: 4.530

Review 7.  More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.

Authors:  M J Moerke; L R McMahon; J L Wilkerson
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

Review 8.  Guidelines on nicotine dose selection for in vivo research.

Authors:  Shannon G Matta; David J Balfour; Neal L Benowitz; R Thomas Boyd; Jerry J Buccafusco; Anthony R Caggiula; Caroline R Craig; Allan C Collins; M Imad Damaj; Eric C Donny; Phillip S Gardiner; Sharon R Grady; Ulrike Heberlein; Sherry S Leonard; Edward D Levin; Ronald J Lukas; Athina Markou; Michael J Marks; Sarah E McCallum; Neeraja Parameswaran; Kenneth A Perkins; Marina R Picciotto; Maryka Quik; Jed E Rose; Adrian Rothenfluh; William R Schafer; Ian P Stolerman; Rachel F Tyndale; Jeanne M Wehner; Jeffrey M Zirger
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

9.  Chronic Nicotine Exposure Abolishes Maternal Systemic and Renal Adaptations to Pregnancy in Rats.

Authors:  Vanessa Meira Ferreira; Clevia Santos Passos; Edgar Maquigussa; Roberto Braz Pontes; Cassia Toledo Bergamaschi; Ruy Ribeiro Campos; Mirian Aparecida Boim
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

Review 10.  Nicotine in Senescence and Atherosclerosis.

Authors:  Ann Marie Centner; Pradeep G Bhide; Gloria Salazar
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.